BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

RXi Pharmaceuticals Corporation

RXi Pharmaceuticals Corporation logo

Founded
2011
Geography
United States of America based

RXi Pharmaceuticals Corporation (NASDAQ: RXII) is developing the next generation of immuno-oncology therapeutics based on its novel RNAi therapeutic platform including self-delivering RNAi (sd-rxRNA®) compounds.

Technologies

RNA-focused Startups  


Posts Mentioning This Company

Biopharma Insights

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet